4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001236927-25-000005
Director sold 46,808 shares at an average $355.31 ($16,631,386)
- Director acquired 46,808 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FRIEDMAN PAUL A · Director
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,203 | $9.45 | $30,268 | 190,367 | D |
| 2025-08-11 | Sale : show line 2 in the form 10b5-1 | −2,903 | $350.19 | $1,016,605 | 187,464 | D |
| 2025-08-11 | Sale : show line 3 in the form 10b5-1 | −300 | $351.04 | $105,312 | 187,164 | D |
| 2025-08-12 | Exercise or conversion : show line 4 in the form 10b5-1 | +43,605 | $9.45 | $412,067 | 230,769 | D |
| 2025-08-12 | Sale : show line 5 in the form 10b5-1 | −3,303 | $350.93 | $1,159,113 | 227,466 | D |
| 2025-08-12 | Sale : show line 6 in the form 10b5-1 | −3,202 | $351.59 | $1,125,806 | 224,264 | D |
| 2025-08-12 | Sale : show line 7 in the form 10b5-1 | −1,382 | $352.61 | $487,309 | 222,882 | D |
| 2025-08-12 | Sale : show line 8 in the form 10b5-1 | −4,768 | $354.06 | $1,688,137 | 218,114 | D |
| Open-market sales · 46,808 sh · avg $355.31 · $16,631,386 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-11 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (Right to Buy) | −3,203 | 172,777 | D |
| 2025-08-12 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (Right to Buy) | −43,605 | 129,172 | D |
Loading xslF345X05/wk-form4_1755121546.xml…